title: Atypical cat scratch disease with vitritis, serous macular detachment, neuroretinitis, and retrobulbar optic neuritis.
authors.forename: Dominic M
authors.initials: DM
authors.lastname: Buzzacco
authors.forename: Martin
authors.initials: M
authors.lastname: Lubow
authors.forename: Frederick H
authors.initials: FH
authors.lastname: Davidorf
authors.forename: Colleen M
authors.initials: CM
authors.lastname: Cebulla
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D018416:Bartonella henselae / Q000276:immunology / Q000302:isolation & purification*; D002372:Cat-Scratch Disease / Q000175:diagnosis* / Q000188:drug therapy; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005128:Eye Diseases / Q000175:diagnosis* / Q000188:drug therapy; D015818:Eye Infections, Bacterial / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D009902:Optic Neuritis / Q000175:diagnosis* / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D012163:Retinal Detachment / Q000175:diagnosis* / Q000188:drug therapy; D012173:Retinitis / Q000175:diagnosis* / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use; D041623:Tomography, Optical Coherence; D014786:Vision Disorders / Q000175:diagnosis; D014792:Visual Acuity / Q000502:physiology; D014794:Visual Fields; D014821:Vitrectomy; D014822:Vitreous Body / Q000473:pathology*
chemical_list: D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D005938:Glucocorticoids; D007074:Immunoglobulin G; D004318:Doxycycline; D011241:Prednisone; D012293:Rifampin